Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Mol Ther. 2021 Apr 7;29(4):1611-1624. doi: 10.1016/j.ymthe.2020.12.010. Epub 2020 Dec 10.
Mol Ther. 2021.
PMID: 33309880
Free PMC article.